Document Type
Article
Date of Original Version
10-14-2015
Abstract
Dengue vaccine development has made significant strides, but a better understanding of how vaccine-induced immune responses correlate with vaccine efficacy can greatly accelerate development, testing, and deployment as well as ameliorate potential risks and safety concerns. Advances in basic immunology knowledge and techniques have already improved our understanding of cell-mediated immunity of natural dengue virus infection and vaccination. We conclude that the evidence base is adequate to argue for inclusion of assessments of cell-mediated immunity as part of clinical trials of dengue vaccines, although further research to identify useful correlates of protective immunity is needed.
Citation/Publisher Attribution
Rothman, A. L., Currier, J. R., Friberg, H. L., & Mathew, A. (2015). Analysis of cell-mediated immune responses in support of dengue vaccine development efforts. Vaccine, 33(50), 7083-7090.
Available at: http://dx.doi.org/10.1016/j.vaccine.2015.09.104
Author Manuscript
This is a pre-publication author manuscript of the final, published article.
Terms of Use
This article is made available under the terms and conditions applicable
towards Open Access Policy Articles, as set forth in our Terms of Use.